Investigation of promoter function in human and animal cells infected with human recombinant adenoviruses expressing rotavirus antigen VP7sc

References

1. Anderson W. F. 1992; Human gene therapy. Science 256:808–813
   [Google Scholar]
2. Andrew M. E., Boyle D. B., Whitfield P. L., Lockett L. J., Anthony I. D., Bellamy A. R., Both G. W. 1990; The immunogenicity of VP7, a rotavirus antigen resident in the ER, is enhanced by cell-surface expression. Journal of Virology 64:4776–4783
   [Google Scholar]
3. Bacchetti S., Graham F. L. 1993; Inhibition of cell proliferation by an adenovirus vector expressing the human wild type-p53 protein. International Journal of Oncology 3:781–788
   [Google Scholar]
4. Berkner K. L. 1988; Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 6:616–629
   [Google Scholar]
5. Both G. W., Lockett L. J., Janardhana V., Edwards S. J., Bellamy A. R., Graham F. L., Prevec L., Andrew M. E. 1993; Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc. Virology 193:940–950
   [Google Scholar]
6. Boyle D. B., Pye A. D., Kockerhans R., Adair B. M., Vrati S., Both G. W. 1994; Characterisation of Australian ovine adenovirus isolates. Veterinary Microbiology 41:281–291
   [Google Scholar]
7. Chanda P. K., Natuk R. J., Mason B. B., Bhat B. M., Greenberg L., Dheer S., Molnar-Kimber K. L., Mizutani S., Lubeck M. D., Davis A. R., Hung P. P. 1990; High level expression of the envelope glycoproteins of the human immunodeficiency virus type 1 in the presence of rev gene using helper-independent adenovirus type 7 recombinants. Virology 175:535–547
   [Google Scholar]
8. Conner M. E., Crawford S. E., Barone C., Estes M. K. 1993; Rotavirus vaccine administered parenterally induces protective immunity. Journal of Virology 67:6633–6641
   [Google Scholar]
9. Conner M. E., Matson D. O., Estes M. K. 1994; Rotavirus vaccines and vaccination potential. Current Topics in Microbiology and Immunology 185:286–337
   [Google Scholar]
10. Couch R. B., Chanock R. M., Cate T. R., Lang D. J., Knight V., Heubner R. J. 1963; Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract. American Review of Respiratory Disease 88:394–403
    [Google Scholar]
11. Davidson D., Hassell J. A. 1987; Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector. Journal of Virology 61:1226–1239
    [Google Scholar]
12. Ginsberg H. S., Lundholm-Beauchamp U., Horswood R. L., Pernis B., Wold W. S. M., Chanock R. M., Prince G. A. 1989; Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proceedings of the National Academy of Sciences USA 86:3823–3827
    [Google Scholar]
13. Gluzman Y. 1981; SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23:175–182
    [Google Scholar]
14. Gooding L. R. 1992; Virus proteins that counteract host immune defenses. Cell 71:5–7
    [Google Scholar]
15. Graham F. L., Prevec L. 1991; Manipulation of adenovirus vectors. In Methods in Molecular Biology pp 1–19 Edited by Murray E. J., Walker J. M. Clifton, New Jersey: Humana Press;
    [Google Scholar]
16. Graham F. L., van der Eb A. J. 1973; A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467
    [Google Scholar]
17. Graham F. L., Prevec L. 1992; Adenovirus based expression vectors and recombinant vaccines. In Vaccines: New Approaches to Immunological Problems pp 363–390 Edited by Elliss W. R. Stoneham, Mass: Butterworth-Heinemann;
    [Google Scholar]
18. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36:59–72
    [Google Scholar]
19. Gunning P., Leavitt J., Muscat G., Ng S.-Y., Redes L. 1987; A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proceedings of the National Academy of Sciences USA 84:4831–4835
    [Google Scholar]
20. Hitt M., Bett A., Addison C., Prevec L., Graham F. L. (In Press) Human adenovirus vector construction and characterisation. Methods in Molecular Genetics
    [Google Scholar]
21. Horwitz M. S. 1990; Adenoviruses. In Virology pp 1723–1740 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
22. Jacobs S. C., Stephenson J. R., Wilkinson G. W. G. 1992; High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector-protection elicited in a murine model. Journal of Virology 66:2086–095
    [Google Scholar]
23. Johnson D. C., Ghosh-Choudhury G., Smiley J. R., Fallis L., Graham F. L. 1988; Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology 164:1–14
    [Google Scholar]
24. Kapikian A. Z., Chanock R. M. 1990; Rotaviruses. In Virology pp 1353–1404 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
25. Levrero M., Barban V., Manteca S., Ballay A., Balsamo C., Avantaggiati M. L., Natoli G., Skellekens H., Tiollais P., Perricaijdet M. 1991; Defective and nondefective adenovirus vectors for expressing foreign genes in-vitro and in-vivo. GENE (Amsterdam) 101:195–202
    [Google Scholar]
26. Lewis A. M., Levine A. S., Crumpacker C. S., Levin M. J., Samaha R. J., Henry P. H. 1973; Studies of non-defective adenovirus 2-SV40 specific biological properties. Journal of Virology 11:655–664
    [Google Scholar]
27. Liu F., Green M. R. 1994; Promoter targeting by adenovirus-Ela through interaction with different cellular DNA-binding domains. Nature 368:520–525
    [Google Scholar]
28. Mason B. B., Davis A. R., Bhat B. M., Chengalvala M., Lubeck M. D., Zandle G., Kostek B., Cholodofsky S., Dheer S., Molnar-Kimber K., Mizutani S., Hung P. P. 1990; Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron. Virology 177:452–461
    [Google Scholar]
29. McGrory W. J., Bautista D. S., Graham F. L. 1988; A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 163:614–617
    [Google Scholar]
30. Mittal S. K., McDermott M. R., Johnson D. D., Prevec L., Graham F. L. 1993; Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Research 28:67–90
    [Google Scholar]
31. Morgenstern J. P., Land H. 1990; A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Research 18:1068
    [Google Scholar]
32. Morin J. E., Lubeck M. D., Barton J. E., Conley A. J., Davis A. R., Hung P. P. 1987; Recombinant adenovirus induces antibody responses to hepatitis B virus surface antigen in hamsters. Proceedings of the National Academy of Sciences USA 84:4626–4630
    [Google Scholar]
33. Morsy M. A., Alford E. L., Bett A., Graham F. L., Caskey C. T. 1993; Efficient adenoviral vector mediated ornithine trans-carbamylase expression in deficient mouse and human hepatocytes. Journal of Clinical Investigation 92:1580–1586
    [Google Scholar]
34. Mulligan R. C. 1993; The basic science of gene therapy. Science 260:926–932
    [Google Scholar]
35. Offit P. A. 1994; Rotaviruses: immunologic determinants of protection against infection and disease. Advances in Virus Research 44:161–202
    [Google Scholar]
36. Schaller J. P., Saif L. J., Cordle C. T., Candler E., Winship T. R., Smith K. L. 1992; Prevention of human rotavirus-induced diarrhea in gnotobiotic piglets using bovine antibody. Journal of Infectious Diseases 165:623–630
    [Google Scholar]
37. Schneider M., Graham F. L., Prevec L. 1989; Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors. Journal of General Virology 70:417–427
    [Google Scholar]
38. Spessot R., Inchley K., Hupel T. M., Bacchetti S. 1989; Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication. Virology 168:378–387
    [Google Scholar]
39. Sprague J., Condra J. H., Arnheiter H., Lazzarini R. A. 1983; Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein. Journal of Virology 43:369–378
    [Google Scholar]
40. Top F. H. Jr, Buescher E. L., Bancroft W. H., Russell P. K. 1971; Immunization with live types 4 and 7 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. Journal of Infectious Diseases 124:155–160
    [Google Scholar]
41. Ward R. L., McNeal M. M., Sheridan J. F. 1990; Development of an adult mouse model for studies on protection in rotavirus. Journal of Virology 64:5070–5075
    [Google Scholar]
42. Wold W. S. M., Gooding L. R. 1991; Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1–8
    [Google Scholar]
43. York I. A., Roop C., Andrews D. W., Riddell S. R., Graham F. L., Johnson D. C. 1994; A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8 (+) T lymphocytes. Cell 77:525–535
    [Google Scholar]